BOSTON SCIENTIFIC CORP — Director's Dealing 2021

Feb 17, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BOSTON SCIENTIFIC CORP (BSX)
CIK: 0000885725
Period of Report: 2021-02-15

Reporting Person: Pierce David A (EVP Pres MedSurg)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-02-15	Common Stock	M	2768.0000	$0.0000	Acquired	12428.0000	Direct
2021-02-15	Common Stock	F	1228.0000	$38.3900	Disposed	11200.0000	Direct
2021-02-16	Common Stock	S	1540.0000	$38.2800	Disposed	9660.0000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-02-15	Deferred Stock Units	$	M	2768.0000	Disposed	2023-02-15	Common Stock (2768.0000)	Direct

Footnotes

F1: Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.

F2: This transaction was effected pursuant to a pre-established Rule 10b5-1 trading plan.

F3: Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 15, 2019, the first anniversary of the date of grant.